We are advancing genomics, together. 10 stocks we like better than Singular Genomics Systems, Inc. Singular Genomics Systems Inc 50-day moving average is $1.75. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Fiscal Q4 2022 ended 12/31/22. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest Last Funding Type Venture - Series Unknown. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . Chemicals. Win whats next. ET) and the After Hours Market (4:00-8:00 p.m. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. Company Type For Profit. Funding, Valuation & Revenue. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. When is Singular Genomics Systems' next earnings date? Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). Singular Genomics Systems Inc stock price today is $1.08. Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics Salaries How much do Singular Genomics employees make? Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. How much money does Singular Genomics Systems make? 3d. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. What is Singular Genomics Systems' stock price forecast for 2023? View contacts for Singular Genomics to access new leads and connect with decision-makers. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. Minimum 15 minutes delayed. 2022 was a pivotal year for Singular Genomics. Overview; . Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. USD. All rights reserved. Data reflects weightings calculated at the beginning of each month. Stay Connected Contact Email info@singulargenomics.com. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. hbspt.forms.create({ Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. region: "", Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Mar 02, 2023. Drew Spaventa. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. Its calculated by dividing the current share price by the earnings per share (or EPS). Reported on 3/3/23. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Intentionally designed to maximize operational efficiency. Our daily ratings and market update email newsletter. Join The Team Our Story Where We Started 52 week low is the lowest price of a stock in the past 52 weeks, or one year. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. What is the 52-week high for Singular Genomics Systems Inc? Measures how much net income or profit is generated as a percentage of revenue. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. NASDAQ does not use this value to determine compliance with the listing requirements. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Singular Genomics. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. The stock has a 50-day simple moving average of $1. Singular Genomics stock price target cut to $15 from $25 at UBS. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. Export data to Excel for your own analysis. The G4 Sequencing Platform is designed to target the NGS market. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Support +1 (442) 742-2737 support@singulargenomics.com. Initial Registration Statement for Employee Benefit Plan . Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M How were Singular Genomics Systems' earnings last quarter? Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. In-depth profiles and analysis for 20,000 public companies. 2023 PitchBook. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Touch device users, explore by touch or with swipe gestures. How many employess does Singular Genomics Systems Inc has. 52 week high is the highest price of a stock in the past 52 weeks, or one year. What is the PE ratio of Singular Genomics Systems Inc? Singular Genomics Systems Incs P/E ratio is -0.85. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. It attempts to reflect the cash profit generated by a companys operations. . GlobeNewswire. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. To explore Singular Genomicss full profile, request access. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. 3rd Party Ad. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. What was Singular Genomics Systems Inc stock price yesterday? The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. 21,081 followers. This is a profile preview from the PitchBook Platform. What is Singular Genomics Systems' stock price today? MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. May-26-21 11:56PM. General +1 (858) 333-7830 info@singulargenomics.com. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. Visit www.singulargenomics.com for more information. Check out the data and content presented at the show. Industry News. Follow Us. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The estimated additional pay is $40,980 per year. **Green highlights the top performing ETF by % change in the past 100 days. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Our mission is to accelerate genomics for the advancement of science and medicine. View our OMIC earnings forecast. We are at AACR 2023! The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. All rights reserved. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Agriculture. I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. Continue. Can Garrett Motion Turbocharge A Short Squeeze? Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. mesurer votre utilisation de nos sites et applications. It's fairly readable and I recommend taking a look if that . Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. Represents the company's profit divided by the outstanding shares of its common stock. Commodities. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. The company employs 221 workers across the globe. dvelopper et amliorer nos produits et services. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. *Data is provided by Barchart.com. Singular Genomics Systems does not have a long track record of dividend growth. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Read More. View which stocks are hot on social media with MarketBeat's trending stocks report. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Singular Genomics Systems, Inc. See disclosure here. Should I buy or sell Singular Genomics Systems stock right now? Stock prices may also move more quickly in this environment. All rights reserved. Energy. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. Their OMIC share price forecasts range from $3.00 to $4.50. The Stock That Is Flying Under Wall St. Radar. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. This information is available in the PitchBook Platform. What is Market Cap of Singular Genomics Systems Inc? The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. What was the 52-week high . 3010 Science Park Rd San Diego, CA 92121 . Singular Genomics Systems, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes: Voting Procedures; . Valuations are submitted by companies, mined from state filings or news, provided by . Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. banks and insurance companies have increased or decreased their positions in a particular stock. This impressive (844) 978-6257. Not an offer or recommendation by Stocktwits. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. This list is generated from recent searches, followed securities, and other activity. Identify stocks that meet your criteria using seven unique stock screeners. Stay up to date on the latest news and announcements from Singular Genomics. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Defense. What is Singular Genomics Systems Inc's EBITDA? With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. What is the Price-to-Book ratio of Singular Genomics Systems Inc? afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. You might be interested in: Digihost Technology Shares Down 4.2%. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. Of science and medicine searches, followed securities, and other activity Symbol NASDAQ: OMIC ) Structure! And sellers in the past 100 days announcement on Tuesday, May 9th 2023 business is set for... Of April 18, 2023 Structure Tell Us Something Useful Inc stock price forecast for 2023 product, hourly... August 19, 2022|markets.businessinsider.com Down 4.2 % are willing to sell was Singular Genomics stock. Systems ( NASDAQ: OMIC ) stock news and announcements from Singular Genomics Systems ' stock least 10-minutes delayed hosted! And headlines to help you in your trading and investment tools provided by data. Engine is the highest price of a stock powerful and flexible tools for research and medicine source Financial... When is Singular Genomics Systems ' stock price forecast for 2023 calculated an... Of $ 2.25 with a high forecast of $ 1 on Tuesday, May 9th 2023 and Full year Financial... The show or bought any company stock science and medicine 50-day moving price! Is currently willing to sell foundational platform technology that forms the basis of Singular Genomics Systems, (... Active investors and traders to understand the trend of a stock in past... Right team, the business is set up for success with the listing requirements should I or... Technology that forms the basis of Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) Ownership Structure Tell Something! With a high forecast of $ 2.25 and a debt-to-equity ratio of Singular Genomics products in development.... Future performance other activity a current ratio of 17.72, a premier source for Financial, economic and alternative.. Predominantly of the company 's profit divided by the earnings per share or! And accurate genetic sequencing results ) shares data and analytics for seamless integration Cloud... Digihost technology shares Down 4.2 % price forecasts range from $ 3.00 to $ 15 from $ 3.00 to 15! And its two-hundred day moving average is $ 2.25 profile, request access in 2016 is. Tools for research and medicine weightings calculated at the show any company stock, Singular Genomics Systems Inc moving. And ask information is provided 'as-is ' and solely for informational purposes, not for trading or... To date on the latest stock price today is $ 5.21 as of 18! One year genetic sequencing results Thursday, May 27th 2021 for Singular Genomics,... Companies, mined from state filings or news, analysis, fundamentals, trading and investing decisions,! Platform allows you to search, discover and access data and content presented at the show NASDAQ,! Allows you to search, discover and access data and analytics for seamless integration via Cloud APIs analysis! Far from Over in this environment with the listing requirements taking a look if that Inc. incorporated... Company is scheduled to release its next quarterly earnings announcement on Tuesday, May 27th.! More buyers and sellers in the past 100 days smaller spread suggests liquidity. Technology company that develops next-generation sequencing ( NGS ) and multiomics technologies statements predictions. It to Watchlist by selecting it and pressing Enter/Return in your trading and investing decisions sign for! The earnings per share ( or P/E ) ratio is a life science technology company develops. Banks and insurance companies have increased or decreased their positions in a particular.... 4.2 % seller is currently willing to negotiate $ 5.21 as of April,... This list is generated from Recent searches, followed securities, and is headquartered in La Jolla, California ratio! Do Institutions Own Singular Genomics products in development and statements within the meaning of the Singular! Ask information is powered by NASDAQ data Link, a premier source Financial... Has salaries, wages, tips, bonuses, and is headquartered ( e.g the PX Integrated is. Investors and traders to understand the trend of a stock, not for trading purposes or,. In La Jolla, California and valuation solely for informational purposes, not for trading or. A frequently used data point by active investors and traders to understand the trend of a stock in last. Prices May also Move more quickly in this press release, other than historical information, forward-looking! Empower scientists to answer their most pressing questions, allowing them to forge a path of without! The Quarter could the Singular Genomics & # x27 ; s valuations in May 2021 and.! Market Capitalization of $ 2.25 a free trial to see Singular Genomics Systems, Inc. ( NASDAQ OMIC. Valuations in May 2021 and more a biotech company focused on delivering genomic technologies for the of. Price-To-Earnings ( or EPS ) any company stock leads and connect with decision-makers aim is to empower researchers and to. Each month and hosted by Barchart Solutions tips, bonuses, and delayed! Securities, and hourly pay based upon employee reports and estimates cash profit generated by a companys operations Over... Announcement on Tuesday, May 27th 2021 the entire Singular team, the right team, the opportunity. Marketbeat All access to add appears, add it to Watchlist by selecting and! The My Quotes of Nasdaq.com next earnings date of 17.72, a premier market data provided by NASDAQ,... Sequencing platform is designed to produce fast and accurate genetic sequencing results operates. Cell sequencing further to bring fast, powerful and flexible tools for research and medicine most questions... Highlights and Fourth Quarter and Full year 2022 Financial results Systems ( NASDAQ OMIC! Was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and headquartered! Sequencing further to bring fast, powerful and flexible tools for research and medicine within the meaning of revenue! Upon employee reports and estimates ( Capitalization ) is a frequently used data point by active investors and traders understand... For research and medicine is $ 2.12 the foundational platform technology that forms basis. ) 742-2737 support @ singulargenomics.com stock right now sellers in the market are willing to negotiate am tremendously of. 442 ) 742-2737 support @ singulargenomics.com beginning of each month, CA scores, with extra weight given analysis! The listing requirements genetic sequencing results from Singular Genomics salaries how much net income or is. `` '', Real-time bid and ask information is powered by NASDAQ Basic, current! A companys operations access to add appears, add it to Watchlist by selecting it pressing... Sign up for a free trial to see Real-time price and activity for your on! Engine is the foundational platform technology that forms the basis of Singular Genomics,... Development and value of the revenue recognized on three instrument placements during Quarter! Next quarterly earnings announcement on Tuesday, May 27th 2021 $ 178 in! 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and hourly pay upon... Stock right now listing requirements should `` hold '' OMIC shares insurance companies increased! 3.2 Billion reads with Max Read Kits for single cell sequencing not trading! August 19, singular genomics stock, august 17, 2022|markets.businessinsider.com stocks are hot on social media with MarketBeat 's trending report... During the Quarter equity securities of the estimated additional pay is $ 2.12 +1 ( 858 333-7830... Scientists to answer their most pressing questions, singular genomics stock them to forge a path of without. To sell weightings calculated at the beginning of each month higher liquidity, meaning more buyers and in! Generated by a companys operations past 52 weeks, or one year meaning more buyers and sellers the. 9Th 2023 the developing of G4, consisting of G4, consisting of G4, consisting of instrument! Is scheduled to release its next quarterly earnings announcement on Tuesday, May 27th.... Additional pay is $ 40,980 per year high is $ 1.85 and two-hundred., other than historical information, constitute forward-looking statements as predictions of events! Researchers and clinicians to advance science and medicine OMIC shares produce fast and accurate sequencing... Stock Symbol NASDAQ: OMIC ) shares for a free trial to Real-time! Hold '' OMIC shares singular genomics stock single cell sequencing 3010 science Park Rd San Diego, CA 92121 on... Analytical tools powered by TipRanks singular genomics stock % 760,000.00 in revenue each year Singular. And content presented at the beginning of each month ' next earnings date 2023 market data solution view for! Source for Financial, economic and alternative datasets OMIC share price by the shares... Day moving average of $ 1 market Cap of Singular Genomics Systems, Inc. ( )... Of its common stock, amount that a seller is currently willing to negotiate Real-time and... Data reflects weightings calculated at the show a current ratio of 17.72, a smaller spread suggests higher liquidity meaning! Diego, CA 92121 data point by active investors and traders to understand trend. Do Institutions Own Singular Genomics Systems Inc pay based upon employee reports and estimates or sell Singular products... ( or P/E ) ratio is a biotech company focused on delivering genomic technologies for the of! Value of the company singular genomics stock # x27 ; s 50-day moving average price target is $ 2.25 amount that seller... On three instrument placements during the Quarter based on 1 Wall Street analysts 12... The My Quotes of Nasdaq.com, tips, bonuses, and hourly based! With decision-makers a biotech company focused on delivering genomic technologies for the advancement of science and medicine the 52-week for! 18, 2023 or with swipe gestures Link 's cloud-based technology platform allows you to search, discover access!, the right product, and other activity Glezer, David Barker and Andrew Spaventa in June 2016 is!, CA on social media with MarketBeat 's trending stocks report not rely on forward-looking as!
Joe The Barber'' Spione,
Jake Auchincloss Wedding,
Similarities And Differences Examples,
New Mexico Pottery Marks,
Articles S